Abstract:Kang-Xin Li, 1, &ast Hui Yuan, 1, &ast Jing Zhang, 2, 3 Xiao-bin Peng, 1 Wei-Fen Zhuang, 1 Wen-Tao Huang, 1 Hui-Xin Liang, 1 Ying Lin, 1 Ying-Zhen Huang, 1 Shu-Lan Qin 1 1 Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330004, People's Republic of China; 3 China Resources Jiangzhong Pharmaceutical Group Co., Ltd., Nanchang, Jiangxi, 330004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shu-Lan Qin, Email Introduction: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterised by insulin resistance, hyperglycaemia, and inflammation, with oxidative stress contributing to its progression. Curcumin (CUR), known for its anti-inflammatory, antioxidant, and insulin sensitising effects, has shown potential for the treatment of T2DM but is limited by low solubility and bioavailability. This study investigated long-circulating curcumin-loaded liposomes (CUR-LPs) to improve curcumin stability, solubility, and circulation and assessed their effect on insulin resistance in a murine model of T2DM. Methods: CUR-LPs were prepared using the ethanol injection method and characterized for morphology, particle size, zeta potential, encapsulation efficiency, drug-loading capacity, and in vitro release. Cell viability was tested on murine L929 cells. In a T2DM murine model, after four weeks of CUR-LP treatment, inflammatory markers TNF-α and IL-6 were measured by real-time polymerase chain reaction, and liver tissues were analyzed for glutathione (GSH) and superoxide dismutase (SOD) via colorimetry. Results: CUR-LPs were spherical, with an average diameter of (249 ± 2.3) nm and a zeta potential of (− 33.5 ± 0.8) mV. They exhibited an encapsulation efficiency of (99.2 ± 0.5) %and a drug-loading capacity of (1.63 ± 0.02) %. CUR embedding in liposomes significantly maintained CUR release. In L929 cells, over 80% viability was maintained at 12 uM CUR concentration after 24 h. In HFD/STZ-induced T2DM mice, CUR-LPs improved blood glucose and insulin levels more efficiently than free CUR, and CUR-LPs also reduced hepatic inflammation (TNF-α, IL-6), enhanced hepatic GSH and SOD, and attenuated liver injury. Conclusion: CUR-LPs improved glucose metabolism and insulin resistance in HFD/STZ-induced T2DM mice, which may be associated with a decrease in liver inflammation and oxidative stress. Keyworks: T2DM, curcumin, liposomes, insulin resistance, glucose metabolism, oxidative stress Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion and/or insulin action, with Type 2 diabetes mellitus (T2DM) accounting for 90–95% of diabetes patients. 1 T2DM is a metabolic disease characterized by hyperglycemia and occurs due to a variety of complex physiological and pathological processes, with insulin resistance being a hallmark characterizing. 2 Insulin resistance has a complex pathology, which is promoted by multiple factors, including inflammation and oxidation stress. 3 Inflammation and insulin resistance are closely related, and inflammatory cytokines such as TNF-α and IL-6 can inhibit insulin signaling through various mechanisms. 4 Along with inflammation, oxidative stress is also a key factor in the development of insulin resistance and T2DM. High blood glucose levels produce reactive oxygen species, which are key contributors to oxidative stress. 5 Curcumin (CUR) is a polyphenol with a relatively small molecular mass and is the most effective ingredient in turmeric, can activate multiple cell signal pathways in the body, inhibit the formation of advanced glycation end products, reduce the generation of inflammatory factors, and show antioxidant stress effects, thereby protecting islet βcells, improving glucose metabolism, and combating insulin resistance. 6 In addition, previous studies have shown that CUR can improve blood lipid levels, stimulate the antioxidant defense mechanism, and improve mitochondrial dysfunction. 7 Studies have shown that the main active ingredients of turmeric have a significant treatment effect on diabetes. 8 However, CUR has poor water solubility, is easily oxidized in vitro, has low bioavailability, and is metabolized rapidly. Therefore, CUR as a therapeutic agent has greatly limited its clinical applicat -Abstract Truncated-

Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota

Research Progress on the Relationship between High-fat Diet, Intestinal Flora, Bile Acid Metabolism and Insulin Resistance

Curcumin Rescues High Fat Diet-Induced Obesity and Insulin Sensitivity in Mice Through Regulating SREBP Pathway.

Dietary curcumin enhances insulin clearance in diet-induced obese mice via regulation of hepatic PI3K-AKT axis and IDE, and preservation of islet integrity

Curcumin Improved Glucose Intolerance, Renal Injury, and Nonalcoholic Fatty Liver Disease and Decreased Chromium Loss through Urine in Obese Mice

Curcumin-Loaded Long-Circulation Liposomes Ameliorate Insulin Resistance in Type 2 Diabetic Mice

Dietary curcumin restores insulin homeostasis in diet-induced obese aged mice

Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling

Gut microbiota mediates the effects of curcumin on enhancing Ucp1-dependent thermogenesis and improving high-fat diet-induced obesity

Effects of Curcumin on Insulin Resistance in Simple Obesity Rats

Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells

Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis

Curcumin and insulin resistance-Molecular targets and clinical evidences

Screening potential biomarkers associated with insulin resistance in high-fat diet-fed mice by integrating metagenomics and untargeted metabolomics

Quercetin Ameliorates Insulin Resistance and Restores Gut Microbiome in Mice on High-Fat Diets

Curcumin and Other Dietary Polyphenols: Potential Mechanisms of Metabolic Actions and Therapy for Diabetes and Obesity

Effects of Curcumin in a Mouse Model of Very High Fat Diet-Induced Obesity

1H-NMR and MS Based Metabolomics Study of the Intervention Effect of Curcumin on Hyperlipidemia Mice Induced by High-Fat Diet

Metformin increases tauroursodeoxycholic acid levels to improve insulin resistance in diet-induced obese mice

Dihydromyricetin promotes GLP-1 secretion to improve insulin resistance via "gut microbiota-CDCA"

The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium-induced colitis mice: effects of curcumin